Operating Income Summary of Sanofi

Sanofi's latest annual operating income in 2023 was 7.87 Billion EUR , down -13.82% from previous year.
Sanofi's latest quarterly operating income in 2024 Q2 was 5.46 Billion EUR , down -19.88% from previous quarter.
Sanofi reported an annual operating income of 10.65 Billion EUR in 2022, up 31.13% from previous year.
Sanofi reported an annual operating income of 8.12 Billion EUR in 2021, down -42.42% from previous year.
Sanofi reported a quarterly operating income of 5.46 Billion EUR for 2024 Q2, down -19.88% from previous quarter.
Sanofi reported a quarterly operating income of 4.77 Billion EUR for 2023 Q4, up 48.71% from previous quarter.

Annual Operating Income Chart of Sanofi (2023 - 1999)

Historical Annual Operating Income of Sanofi (2023 - 1999)

Year	Operating Income	Operating Income Growth
2023	7.87 Billion EUR	-13.82%
2022	10.65 Billion EUR	31.13%
2021	8.12 Billion EUR	-42.42%
2020	14.11 Billion EUR	362.57%
2019	3.05 Billion EUR	-34.75%
2018	4.67 Billion EUR	-19.43%
2017	5.8 Billion EUR	-11.13%
2016	6.53 Billion EUR	16.13%
2015	5.62 Billion EUR	-7.26%
2014	6.06 Billion EUR	21.72%
2013	4.98 Billion EUR	-22.52%
2012	6.43 Billion EUR	9.71%
2011	5.86 Billion EUR	-10.31%
2010	6.53 Billion EUR	2.65%
2009	6.36 Billion EUR	44.88%
2008	4.39 Billion EUR	-25.66%
2007	5.91 Billion EUR	3.18%
2006	5.72 Billion EUR	20.63%
2005	4.74 Billion EUR	63.9%
2004	2.89 Billion EUR	-5.61%
2003	3.06 Billion EUR	17.35%
2002	2.61 Billion EUR	24.21%
2001	2.1 Billion EUR	33.54%
2000	1.57 Billion EUR	62.41%
1999	971 Million EUR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	1.44 Billion EUR	-63.95%
2024 Q2	5.46 Billion EUR	-19.88%
2023 Q4	4.77 Billion EUR	48.71%
2023 Q2	1.85 Billion EUR	-24.52%
2023 Q3	3.21 Billion EUR	72.73%
2023 Q1	2.46 Billion EUR	-39.97%
2023 FY	9.18 Billion EUR	-13.82%
2022 FY	10.65 Billion EUR	31.13%
2022 Q3	2.72 Billion EUR	90.22%
2022 Q1	2.39 Billion EUR	62.95%
2022 Q2	1.43 Billion EUR	-40.26%
2022 Q4	4.1 Billion EUR	50.62%
2021 Q2	1.55 Billion EUR	-24.44%
2021 Q3	3.03 Billion EUR	94.98%
2021 Q4	1.47 Billion EUR	-51.48%
2021 FY	8.12 Billion EUR	-42.42%
2021 Q1	2.05 Billion EUR	36.38%
2020 Q4	1.5 Billion EUR	-42.27%
2020 Q1	2.04 Billion EUR	1819.33%
2020 FY	14.11 Billion EUR	362.57%
2020 Q3	2.61 Billion EUR	-67.58%
2020 Q2	8.06 Billion EUR	294.04%
2019 Q3	2.13 Billion EUR	817.85%
2019 Q2	-297 Million EUR	-121.08%
2019 Q1	1.4 Billion EUR	804.5%
2019 Q4	-119 Million EUR	-105.58%
2019 FY	3.05 Billion EUR	-34.75%
2018 Q3	2.71 Billion EUR	182.41%
2018 Q4	-200 Million EUR	-107.37%
2018 FY	4.67 Billion EUR	-19.43%
2018 Q1	1.2 Billion EUR	60.35%
2018 Q2	961 Million EUR	-19.98%
2017 FY	5.8 Billion EUR	-11.13%
2017 Q3	1.97 Billion EUR	43.85%
2017 Q2	1.37 Billion EUR	-19.17%
2017 Q1	1.7 Billion EUR	9.53%
2017 Q4	749 Million EUR	-62.13%
2016 FY	6.53 Billion EUR	16.13%
2016 Q1	1.15 Billion EUR	325.83%
2016 Q4	1.55 Billion EUR	-35.05%
2016 Q3	2.39 Billion EUR	66.5%
2016 Q2	1.43 Billion EUR	24.44%
2015 Q1	1.3 Billion EUR	-22.85%
2015 Q3	1.95 Billion EUR	0.88%
2015 Q2	1.93 Billion EUR	49.08%
2015 Q4	271 Million EUR	-86.14%
2015 FY	5.62 Billion EUR	-7.26%
2014 Q4	1.68 Billion EUR	-5.55%
2014 FY	6.06 Billion EUR	21.72%
2014 Q3	1.78 Billion EUR	43.18%
2014 Q2	1.24 Billion EUR	-12.75%
2014 Q1	1.42 Billion EUR	7.53%
2013 FY	4.98 Billion EUR	-22.52%
2013 Q4	1.32 Billion EUR	-18.28%
2013 Q3	1.62 Billion EUR	137.57%
2013 Q2	684 Million EUR	-53.18%
2013 Q1	1.46 Billion EUR	265.25%
2012 Q2	1.61 Billion EUR	-27.76%
2012 Q4	400 Million EUR	-81.56%
2012 Q1	2.23 Billion EUR	136.48%
2012 Q3	2.16 Billion EUR	34.64%
2012 FY	6.43 Billion EUR	9.71%
2011 Q2	1.09 Billion EUR	-19.29%
2011 Q1	1.35 Billion EUR	468.2%
2011 Q3	2.33 Billion EUR	112.96%
2011 Q4	943 Million EUR	-59.6%
2011 FY	5.86 Billion EUR	-10.31%
2010 Q3	1.71 Billion EUR	-15.15%
2010 Q1	1.98 Billion EUR	24750.0%
2010 FY	6.53 Billion EUR	2.65%
2010 Q4	239 Million EUR	-86.06%
2010 Q2	2.02 Billion EUR	1.61%
2009 Q1	2.02 Billion EUR	171.26%
2009 Q2	1.25 Billion EUR	-38.01%
2009 Q3	2.14 Billion EUR	70.46%
2009 FY	6.36 Billion EUR	44.88%
2009 Q4	8 Million EUR	-99.63%
2008 Q2	1.48 Billion EUR	-40.51%
2008 Q3	2.58 Billion EUR	74.49%
2008 Q1	2.49 Billion EUR	116.59%
2008 FY	4.39 Billion EUR	-25.66%
2008 Q4	-2.84 Billion EUR	-209.81%
2007 Q2	1.64 Billion EUR	-76.75%
2007 Q1	7.05 Billion EUR	143.83%
2007 Q3	6.96 Billion EUR	324.78%
2007 Q4	-15.03 Billion EUR	-315.67%
2007 FY	5.91 Billion EUR	3.18%
2006 Q4	-16.09 Billion EUR	-318.87%
2006 Q2	1.06 Billion EUR	-26.53%
2006 FY	5.72 Billion EUR	20.63%
2006 Q3	7.35 Billion EUR	592.63%
2006 Q1	1.44 Billion EUR	51.77%
2005 Q4	952.36 Million EUR	-40.07%
2005 Q3	1.58 Billion EUR	44.13%
2005 Q1	77.14 Million EUR	100.77%
2005 Q2	1.1 Billion EUR	1329.32%
2005 FY	4.74 Billion EUR	63.9%
2004 Q3	5.33 Billion EUR	597.46%
2004 Q4	-10.01 Billion EUR	-287.64%
2004 FY	2.89 Billion EUR	-5.61%
2004 Q2	764.91 Million EUR	-65.66%
2004 Q1	2.22 Billion EUR	169.76%
2003 FY	3.06 Billion EUR	17.35%
2003 Q2	694.41 Million EUR	-64.31%
2003 Q1	1.94 Billion EUR	165.94%
2003 Q4	-3.19 Billion EUR	-232.07%
2003 Q3	2.41 Billion EUR	248.12%
2002 Q3	1.87 Billion EUR	204.28%
2002 Q4	-2.95 Billion EUR	-257.68%
2002 FY	2.61 Billion EUR	24.21%
2002 Q2	615.03 Million EUR	0.0%
2001 FY	2.1 Billion EUR	33.54%
2000 FY	1.57 Billion EUR	62.41%
1999 FY	971 Million EUR	0.0%

Peer Operating Income Comparison of Sanofi

Name	Operating Income	Operating Income Difference
Amgen Inc.	7.89 Billion USD	0.279%
AstraZeneca PLC	8.19 Billion USD	3.881%
Biogen Inc.	1.29 Billion USD	-507.264%
Gilead Sciences, Inc.	7.6 Billion USD	-3.55%
MIRA Pharmaceuticals, Inc.	-8.52 Million USD	92463.99%
Scilex Holding Company	-105.43 Million USD	7569.34%
Scilex Holding Company	-105.43 Million USD	7569.34%

Global Stocks Search

Sanofi (SNY)

Operating Income Summary of Sanofi

Annual Operating Income Chart of Sanofi (2023 - 1999)

Historical Annual Operating Income of Sanofi (2023 - 1999)

Peer Operating Income Comparison of Sanofi